Skip to main content
Caplight Logo









Vaxdyn

Vaxdyn

Private
SevilleHealthcare & Life Scienceshttps://vaxdyn.com/

Last Round

Series A

Sep 2, 2024

Total Funding Raised

$25M

Company Overview

Vaxdyn is a biotechnology company that develops vaccines to prevent infections caused by drug-resistant bacteria.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

vaccine developmentAMRantimicrobial resistancesuperbug vaccinebiotechnologyprophylactic vaccinesdrug discoverybacterial infectionmulti-drug resistant bacteriapreclinical developmentbiotech startupvaccine pipelineinfectious diseasepharmaceutical R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vaxdyn Comparables

Compare Vaxdyn with similar companies based on industry and business-model similarity.

Vaxdyn comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Immunethep
87%
Omniose
82%
LimmaTech Biologics
81%

Vaxdyn Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 2, 2024
GrantSep 2, 2024
GrantApr 22, 2024
GrantDec 2, 2021
SeedMar 8, 2021
Grant
Jul 7, 2020

Key People

Founding team and executive leadership

Juan Jose Infante

CEO

Executive Team

Vaxdyn Investors

Notable investors and investment history

Vaxdyn investors
InvestorRounds
European Innovation Council FundGrant, Series A
CARB-XGrant
Bionova CapitalSeed
EIC FundSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 2, 2024

    Secured $3M from the European Innovation Council.

  • Sep 2, 2024

    $14M round led by EIC Fund and European Innovation Council.

Vaxdyn Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vaxdyn Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vaxdyn's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeville
Employee Range12
Year Founded2011
Last FundingSep 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?